Join
Live feed
·
INSIDERFilingvia Quantisnow
Kiniksa Pharmaceuticals International plc logo

CHIEF OPERATING OFFICER Tessari Eben exercised 6,500 units of Class A Ordinary Share at a strike of $8.83 and sold $547,141 worth of Class A Ordinary Share (16,200 units at $33.77), decreasing direct ownership by 19% to 40,215 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KNSA· Kiniksa Pharmaceuticals International plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KNSA (Kiniksa Pharmaceuticals International plc) and more on Quantisnow.

CHIEF OPERATING OFFICER Tessari Eben exercised 6,500 units of Class A Ordinary Share at a strike of $8.83 and sold $547,141 worth of Class A Ordinary Share (16,200 units at $33.77), decreasing direct ownership by 19% to 40,215 units (SEC Form 4) | Quantisnow